SUCLA2 and mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria: Pathogenic variants in SUCLA2 lead to MTDPS-5 disease characterized by neurosensory deafness, early hypotonia, severe developmental delay, progressive neurological decline, muscle contractures, and dystonia/athetosis.